Chugai Pharmaceutical Co., Ltd. (CHGCY)
19.08
-0.25
(-1.29%)
USD |
OTCM |
Oct 02, 16:00
Chugai Pharmaceutical Market Cap : 62.78B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 62.78B |
| October 01, 2026 | 63.61B |
| September 30, 2026 | 64.40B |
| September 29, 2026 | 63.41B |
| September 28, 2026 | 66.08B |
| September 25, 2026 | 69.27B |
| September 24, 2026 | 69.10B |
| September 23, 2026 | 70.65B |
| September 22, 2026 | 71.27B |
| September 21, 2026 | 70.98B |
| September 18, 2026 | 70.75B |
| September 17, 2026 | 70.42B |
| September 16, 2026 | 67.59B |
| September 15, 2026 | 68.38B |
| September 14, 2026 | 68.28B |
| September 11, 2026 | 68.28B |
| September 10, 2026 | 67.49B |
| September 09, 2026 | 68.81B |
| September 08, 2026 | 69.27B |
| September 04, 2026 | 71.04B |
| September 03, 2026 | 72.36B |
| September 02, 2026 | 70.98B |
| September 01, 2026 | 70.68B |
| August 31, 2026 | 70.91B |
| August 28, 2026 | 71.80B |
| Date | Value |
|---|---|
| August 27, 2026 | 71.27B |
| August 26, 2026 | 71.97B |
| August 25, 2026 | 71.90B |
| August 24, 2026 | 71.80B |
| August 21, 2026 | 73.02B |
| August 20, 2026 | 72.69B |
| August 19, 2026 | 72.72B |
| August 18, 2026 | 70.65B |
| August 17, 2026 | 70.58B |
| August 14, 2026 | 70.91B |
| August 13, 2026 | 73.78B |
| August 12, 2026 | 74.43B |
| August 11, 2026 | 73.08B |
| August 10, 2026 | 73.12B |
| August 07, 2026 | 71.27B |
| August 06, 2026 | 69.23B |
| August 05, 2026 | 68.77B |
| August 04, 2026 | 69.76B |
| August 03, 2026 | 69.56B |
| July 31, 2026 | 71.11B |
| July 30, 2026 | 72.89B |
| July 29, 2026 | 70.48B |
| July 28, 2026 | 70.60B |
| July 27, 2026 | 68.87B |
| July 24, 2026 | 71.97B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 56.45B |
| Daiichi Sankyo Co., Ltd. | 31.64B |
| Eisai Co., Ltd. | 8.417B |
| Santen Pharmaceutical Co., Ltd. | 3.389B |
| Ono Pharmaceutical Co., Ltd. | 6.765B |
Market Cap Related Metrics
| PE Ratio | 20.57 |
| PS Ratio | 7.217 |
| PEG Ratio | 1.331 |
| Price to Book Value | 5.032 |
| Price to Free Cash Flow | 25.68 |
| Price | 19.08 |
| Earnings Yield | 4.86% |
| PEGY Ratio | 1.331 |
| Operating PE Ratio | 14.30 |
| Normalized PE Ratio | 19.64 |